EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology

Victor Akpe iD, Ian E Cock iD

Micromachines · 28.04.2026 · 17 (5) · 541

DOI: 10.3390/mi17050541 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Micromachines, online erschienen am 28.04.2026. Verfasst von Victor Akpe und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Environment and Science, Griffith University, Nathan Campus, Brisbane, QLD 4111, Australia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This review evaluates recent progress in nanozyme-based biosensors for detecting circulating tumour cells, nucleic acids, and protein biomarkers, with particular attention to how peroxidase-, oxidase-, and catalase-like reactions enhance signal generation across electrochemical, optical, and microfluidic platforms. The roles of iron oxide–gold composites, silica nanostructures, quantum dots, and hybrid nanomaterials in improving analytical performance, enabling multiplexed detection, and facilitating assay miniaturization are critically assessed. Advances such as amplification-free detection approaches, smartphone-compatible point-of-care systems, and AI-assisted data analysis are discussed in relation to their translational potential. Key barriers, including regulatory requirements, reproducibility concerns, and manufacturing scalability, are also evaluated. By integrating mechanistic understanding with practical considerations for clinical deployment, this review outlines how next-generation nanozyme-based biosensors may strengthen early cancer detection, real-time monitoring, and precision oncology.

Schlagwörter

Stichwörter der Autor:innen

amplification-free assayscancer biomarker detectionmicrofluidic integrationnanozyme-enabled biosensorspoint-of-care diagnosticstranslational oncology

Autor:innen und Institutionen

  • School of Environment and Science, Griffith University, Nathan Campus, Brisbane, QLD 4111, Australia.

ORCID-Profile: Victor Akpe, Ian E Cock

Zitieren

APA

Akpe, V., & Cock, I. E. (2026). Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology. Micromachines, 17(5), 541. https://doi.org/10.3390/mi17050541

Vancouver

Akpe V, Cock IE. Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology. Micromachines. 2026;17(5):541. doi:10.3390/mi17050541

BibTeX
@article{Akpe2026,
  author = {Akpe, Victor and Cock, Ian E},
  title = {Nanozyme-Driven Signal Amplification in Cancer Biosensing: Innovations Toward Precision and Point-of-Care Oncology},
  journal = {Micromachines},
  year = {2026},
  volume = {17},
  number = {5},
  pages = {541},
  doi = {10.3390/mi17050541}
}
Kostenlos starten →